SUSAN EVITTS: Open Payments
NPI 1427042241 · LYKENS, PA. Company-reported industry payments from CMS Open Payments. A payment does not imply wrongdoing.
See the full provider profile for registry, prescribing and billing details.
Industry payments (Sunshine Act)
Source: CMS Open Payments general payments. Payments from drug and device companies are reported by the companies; they do not imply wrongdoing and are separate from Medicare billing.
$370 in 19 payments from 9 companies in 2025. Trend: 2023 $693 · 2024 $474 · 2025 $370
Food & beverage: $370
| Company | Payments | Amount |
|---|---|---|
| ABBVIE INC. | 5 | $117 |
| Novo Nordisk Inc | 4 | $72 |
| GlaxoSmithKline, LLC. | 2 | $50 |
| PFIZER INC. | 3 | $49 |
| E.R. Squibb & Sons, L.L.C. | 1 | $21 |
| Organon LLC | 1 | $18 |
| AstraZeneca Pharmaceuticals LP | 1 | $16 |
| Lilly USA, LLC | 1 | $14 |
| Aimmune Therapeutics, Inc. | 1 | $14 |
Products named: QULIPTA, SHINGRIX, UBRELVY, ELIQUIS, CAMZYOS, PREVNAR 20, Wegovy, FARXIGA.
Industry payments across PA — which companies pay providers there.
